Tag : genome sequencing

Co–Founder Sam Santhosh steps down as Chairman and Group CEO; will remain on Board of Directors Co–founder Mahesh Pratapneni appointed Group CEO Dr. Felix Olale appointed Chairman...

Ranked within top 60 of 500 companies, from more than 2,550 applicants in total Selection based on business size, digital footprint, and sustainability Also listed...

Personalis’ oncology diagnostics business expected to build on foundation of advanced technology already the driver of rapidly growing revenue from pharmaceutical companies Personalis, Inc. (Nasdaq:...

Creyon Bio, Inc. (“Creyon Bio”), a drug development company engineering RNA-based medicines and their components (oligonucleotide-based medicines or OBMs) with predictable safety and efficacy profiles,...

Early data from landmark study shows rapid whole genome sequencing (rWGS) provided diagnostic insights for more than half of newborns who received testing; one-third had no...

Collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules Potential to identify novel product candidates to modulate...

The “Single Cell Genomics Markets: Forecasts by Technology, Product, Workflow, User & Country with Executive and Consultant Guides. Including Customized Forecasting and Analysis” report has been added...

Coalition aims to raise awareness and utilization of cardiogenomic testing to improve patient outcomes. Several leading genomics companies and laboratories, including Illumina, Fulgent Genetics, Invitae,...

Invention enhances company’s capabilities to design highly discriminatory polymerase chain reaction (PCR) assays for rapid, accurate detection and diagnosis. Noblis, Inc., a leading provider of...

On March 22, 2022, OBiO Technology (Shanghai) Corp., Ltd. (“OBiO” or “the Company”), has completed its initial public offering (“IPO”) process and started trading on the...